title: [Transgenic goats in the world's pharmaceutical industry in the XXI century].
abstract: In many developed countries, isolation of human pharmaceutical proteins from milk of genetically modified animals is currently a priority. One of the first commercial pharmaceuticals obtained from the milk of transgenic goats, an anticoagulant antithrombin III, developed by Genzyme Transgenic Corporation, an American biotechnological company, will appear on the pharmaceutical market in the nearest future. In this review, we discuss the role of fundamental science in the development of this field of the pharmaceutical industry.
authors.affiliation: Institute of Gene Biology, Russian Academy of Science, Moscow, 117334 Russia. gold@biogen.msk.su
authors.forename: I L
authors.initials: IL
authors.lastname: Gol'dman
authors.forename: S G
authors.initials: SG
authors.lastname: Kadulin
authors.forename: S V
authors.initials: SV
authors.lastname: Razin
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D004345:Drug Industry; D006041:Goats / Q000235:genetics*; D006801:Humans